0001181431-13-002501.txt : 20130108 0001181431-13-002501.hdr.sgml : 20130108 20130108190514 ACCESSION NUMBER: 0001181431-13-002501 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20130107 FILED AS OF DATE: 20130108 DATE AS OF CHANGE: 20130108 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Singh Nikhilesh N CENTRAL INDEX KEY: 0001454351 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51967 FILM NUMBER: 13519264 MAIL ADDRESS: STREET 1: C/O TRANSCEPT PHARMACEUTICALS INC STREET 2: 1003 W CUTTING BLVD SUITE 110 CITY: POINT RICHMOND STATE: CA ZIP: 94804 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Transcept Pharmaceuticals Inc CENTRAL INDEX KEY: 0001178711 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330960223 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1003 W. CUTTING BLVD STREET 2: SUITE 110 CITY: POINT RICHMOND STATE: CA ZIP: 94804 BUSINESS PHONE: (510) 215-3500 MAIL ADDRESS: STREET 1: 1003 W. CUTTING BLVD STREET 2: SUITE 110 CITY: POINT RICHMOND STATE: CA ZIP: 94804 FORMER COMPANY: FORMER CONFORMED NAME: NOVACEA INC DATE OF NAME CHANGE: 20020724 4 1 rrd366399.xml SINGH ANNUAL OPTION GRANT X0306 4 2013-01-07 0 0001178711 Transcept Pharmaceuticals Inc TSPT 0001454351 Singh Nikhilesh N C/O TRANSCEPT PHARMACEUTICALS, INC. 1003 W. CUTTING BLVD, SUITE 110 POINT RICHMOND CA 94804 0 1 0 0 SVP & Chief Scientific Officer Common Stock 2699 D Common Stock 295 I See footnote Common Stock 78206 I See footnote Common Stock Option (right to buy) 5.4 2013-01-07 4 A 0 120000 0 A 2023-01-07 Common Stock 120000 120000 D This total includes 1,145 shares purchased on November 30, 2012 under the 2009 Employee Stock Purchase Plan. Shares held directly by the Reporting Person's spouse. Shares held directly by the Singh Family Trust (the "Family Trust") for which Reporting Person's spouse serves as trustee. The Reporting Person disclaims beneficial ownership of the shares held by the Family Trust except to the extent of his pecuniary interest therein. The option vests in forty-eight equal monthly installments beginning on February 7, 2013. /s/ Leone D. Patterson, by power of attorney 2013-01-08 EX-24. 2 rrd328993_371823.htm POWER OF ATTORNEY rrd328993_371823.html 
       Exhibit 24

POWER OF ATTORNEY

 Know all by these presents, that the undersigned hereby constitutes and appoints each of (i) the Chief Executive Officer of Transcept Pharmaceuticals, Inc., a Delaware corporation (the "Company"), who is currently Glenn A. Oclassen, (ii) the Company's Chief Operating Officer, who is currently Thomas P. Soloway, and (iii) the Company's Chief Financial Officer, who is currently Leone D. Patterson, and their respective successors, signing singly, the undersigned's true and lawful attorney-in-fact to:

(1)	complete and execute for and on behalf of the undersigned, in the undersigned's capacity as an officer of the Company, Forms 3, 4 and 5 and any other forms (including amendments thereto) in accordance with Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and the rules and regulations thereunder and a Form ID, Uniform Application for Access Codes to File on EDGAR;

(2)	do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Forms 3, 4 or 5, Form ID or any other forms and timely file such forms (including amendments thereto) and application with the United States Securities and Exchange Commission and any securities exchange or similar authority; and

(3)	take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion.

       The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted.  The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the Exchange Act.

       The undersigned agrees that each such attorney-in-fact herein may rely entirely on information furnished orally or in writing by the undersigned to such attorney-in-fact.  The undersigned also agrees to indemnify and hold harmless the Company and each such attorney-in-fact against any losses, claims, damages or liabilities (or actions in these respects) that arise out of or are based upon any untrue statements or omission of necessary facts in the information provided by the undersigned to such attorney-in fact for purposes of executing, acknowledging, delivering or filing Forms 3, 4 or 5, Form ID or any other form (including amendments thereto) and agrees to reimburse the Company and such attorney-in-fact for any legal or other expenses reasonably incurred in connection with investigating or defending against any such loss, claim, damage, liability or action.

       This Power of Attorney supersedes any power of attorney previously executed by the undersigned regarding the purposes outlined in the first paragraph hereof ("Prior Powers of Attorney"), and the authority of the attorneys-in-fact named in any Prior Powers of Attorney is hereby revoked.

       This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4 or 5 with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier (a) revoked by the undersigned in a signed writing delivered to the Company and the foregoing attorneys-in-fact or (b) superseded by a new power of attorney regarding the purposes outlined in the first paragraph hereof dated as of a later date.

       IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 28 day of June, 2012.

/s/ Nikhilesh N. Singh
Nikhilesh N. Singh